Sector portfolio · VC firm · United States

Venrock's Biotech portfolio

Venrock has backed 42 Biotech startups in rounds we track, $6.5B between them, shown by the stage each has reached. The best-funded is Intarcia Therapeutics.

42startups backed
5stages
$6.5Braised between them
Stage not reportedbiggest stage

Venrock's whole portfolioVenrock's profile

Segment by segment

Stage not reported

13 startups · $1.6B raised

  1. Biohaven PharmaceuticalBiohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.United States$280M
  2. Intuity MedicalIntuity Medical develops blood glucose monitoring systems for diabetes management.United States$275M
  3. 10X Genomics10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.United States$215M
  4. IInscriptaUnited States$205M
  5. CelladonCelladon is a biotechnology company developing molecular therapies for the treatment of heart failure.United States$172M
  6. Applied TherapeuticsApplied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.United States$100M
  7. Concentric AnalgesicsConcentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.United States$96M
  8. Virdante PharmaceuticalsVirdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases.United States$60M

Series B

11 startups · $1.4B raised

  1. Expedition TherapeuticsExpedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024.United States$280M
  2. Aeglea BioTherapeuticsAeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.United States$266M
  3. Hua MedicineHua Medicine is a clinical-stage, innovative drug development company in China.China$192M
  4. Keros TherapeuticsKeros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.United States$163M
  5. PharvarisPharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.Switzerland$132M
  6. SonoTheraSonoThera is a biotechnology company based in South San Francisco that focuses on developing ultrasound-guided, nonviral gene therapies.United States$125M
  7. MBrace TherapeuticsMBrace Therapeutics is a clinical-stage biopharmaceutical company founded in 2020 and based in San Diego, California.United States$85M
  8. CCorvidiaCorvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.United States$61M

Series C and later

9 startups · $1.6B raised

  1. Encoded TherapeuticsEncoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.United States$379M
  2. Orchard TherapeuticsOrchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.United Kingdom$377M
  3. Coherus BiosciencesCoherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.United States$299M
  4. Doctor on DemandDoctor On Demand is a nationwide virtual healthcare provider based in San Francisco, offering 24/7 access to board-certified physiUnited States$161M
  5. PPowerVisionPowerVision is a device company developing implantable intraocular lenses.United States$108M
  6. RRefleXionReflexion offers holistic fitness through Pilates and Gyrotonic exercise.United States$100M
  7. Bright Peak TherapeuticsBright Peak Therapeutics is a private biotechnology company founded in 2017, with headquarters in Basel/Allschwil, Switzerland, anSwitzerland$90M
  8. Pathwork DiagnosticsPathwork Diagnostics develops and delivers molecular diagnostic solutions for oncology.United States$64M

Series A

5 startups · $270M raised

  1. Ablaze PharmaceuticalsAblaze Pharmaceuticals is a clinical-stage biopharmaceutical company based in Shanghai, China, with an office in San Diego, California.China$75M
  2. Lusaris TherapeuticsLusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.United States$60M
  3. Federation BioFederation Bio is a biotechnology firm that develops and commercializes therapeutics for the treatment of durably reverse serious diseases.United States$50M
  4. Kelonia TherapeuticsKelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.United States$50M
  5. The Public Health CompanyDeveloping the first global biosecurity platform to provide enterprises a SaaS-enabled service for the management of bio-risks.United States$35M

Growth

4 startups · $1.6B raised

  1. Intarcia TherapeuticsIntarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.United States$1.1B
  2. Element BiosciencesElement Biosciences is a biotechnology company based in San Diego, founded in 2017 by former Illumina scientists.United States$190M
  3. Epic SciencesEpic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.United States$165M
  4. Cerulean PharmaCerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.United States$152M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Venrock as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Venrock?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.